What the Recent Study Found In a 2024 Cell Metabolism study, patients taking atorvastatin (a commonly used statin) showed a nearly 50% drop in their levels of GLP-1, the hormone that GLP-1 agonists (Ozempic, Wegovy, etc.) mimic
Your body's peptide signaling pathwaysgoverned by genetic variants in the GLP1R, GIPR, and FTO genesinfluence how quickly you respond to semaglutide and how vulnerable you are to rebound hunger
After 40 weeks, all three tirzepatide groups lost 4-12 more pounds, on average, than the semaglutide group and came out with healthier diabetic biomarkers.3 Another example is a massive cohort study of 18,386 patients, which found that tirzepatide patients lost 5-15% more weight than their semaglutide counterparts.4 Tirzepatides superior efficacy correlates with a higher cost compared to semaglutide
S., Ortiz-Prado, E., Rico-Fontalvo, J., Gmez-Mesa, J.-E., Abreu-Lomba, A, & Rivera-Martnez, W.-A